Heregulin beta1-activated phosphatidylinositol 3-kinase enhances aggregation of MCF-7 breast cancer cells independent of extracellular signal-regulated kinase - PubMed (original) (raw)
. 1999 Apr 1;59(7):1620-5.
Affiliations
- PMID: 10197638
Heregulin beta1-activated phosphatidylinositol 3-kinase enhances aggregation of MCF-7 breast cancer cells independent of extracellular signal-regulated kinase
M Tan et al. Cancer Res. 1999.
Abstract
Heregulin (HRG) is a family of polypeptide growth factors derived from alternatively spliced genes. HRG can bind to receptor tyrosine kinases erbB3 and erbB4, thereby inducing erbB3 and erbB4 heterodimerization with erbB2, leading to receptor tyrosine phosphorylation and activating downstream signal transduction. Cell-cell homophilic adhesion (cell aggregation) is important in determining the structural organization and behavior of cells in tissues. In addition, tumor cell homophilic adhesion may affect invasive and metastatic potentials of cells. We report that HRG-beta1 can enhance aggregation of MCF-7 and SKBR3 human breast cancer cells. While investigating the downstream signals involved in HRG-beta1-enhanced cell aggregation, we observed that HRG-beta1 induced tyrosine phosphorylation of erbB2 and crbB3 receptor heterodimers and increased the association of the dimerized receptors with the 85-kDa subunit of phosphatidylinositol 3-kinase (PI3K). HRG-beta also increased the kinase activities of extracellular signal-regulated protein kinase (ERK) and PI3K in these cells. By using the mitogen-activated protein kinase/ERK 1 (MEK1) inhibitor PD98059 and PI3K inhibitors wortmannin and LY294002, we found that blocking the MEK1-ERK pathway had no effect on HRG-pbeta1-enhanced cell aggregation; however, blocking the PI3K pathway greatly inhibited HRG-beta1-mediated cell aggregation. Our study indicated that the HRG-beta1-activated MEK1-ERK pathway has no demonstrable role in the induction of cell aggregation, whereas HRG-beta1-activated PI3K is required for enhancing breast cancer cell aggregation. Because aggregation can contribute to invasion/metastasis phenotype of cancer cells, our results have provided one mechanism by which HRG-beta1-activated signaling of erbB receptors may affect invasive/metastatic properties of MCF-7 and SKBR3 breast cancer cells.
Similar articles
- Heregulin-beta is especially potent in activating phosphatidylinositol 3-kinase in nontransformed human mammary epithelial cells.
Ram TG, Hosick HL, Ethier SP. Ram TG, et al. J Cell Physiol. 2000 Jun;183(3):301-13. doi: 10.1002/(SICI)1097-4652(200006)183:3<301::AID-JCP2>3.0.CO;2-W. J Cell Physiol. 2000. PMID: 10797304 - The relative role of ErbB1-4 receptor tyrosine kinases in radiation signal transduction responses of human carcinoma cells.
Bowers G, Reardon D, Hewitt T, Dent P, Mikkelsen RB, Valerie K, Lammering G, Amir C, Schmidt-Ullrich RK. Bowers G, et al. Oncogene. 2001 Mar 15;20(11):1388-97. doi: 10.1038/sj.onc.1204255. Oncogene. 2001. PMID: 11313882 Review. - Interaction between erbB-receptors and heregulin in breast cancer tumor progression and drug resistance.
Lupu R, Cardillo M, Harris L, Hijazi M, Rosenberg K. Lupu R, et al. Semin Cancer Biol. 1995 Jun;6(3):135-45. doi: 10.1006/scbi.1995.0016. Semin Cancer Biol. 1995. PMID: 7495981 Review.
Cited by
- Expression of EGFR isoform D is regulated by HER receptor activators in breast cancer cells.
Negrón-Vega L, Cora EM, Pérez-Torres M, Tang SC, Maihle NJ, Ryu JS. Negrón-Vega L, et al. Biochem Biophys Rep. 2022 Aug 19;31:101326. doi: 10.1016/j.bbrep.2022.101326. eCollection 2022 Sep. Biochem Biophys Rep. 2022. PMID: 36039113 Free PMC article. - Salivary gland development and disease.
Mattingly A, Finley JK, Knox SM. Mattingly A, et al. Wiley Interdiscip Rev Dev Biol. 2015 Nov-Dec;4(6):573-90. doi: 10.1002/wdev.194. Epub 2015 May 13. Wiley Interdiscip Rev Dev Biol. 2015. PMID: 25970268 Free PMC article. Review. - Neuregulin mediates F-actin-driven cell migration through inhibition of protein kinase D1 via Rac1 protein.
Döppler H, Bastea LI, Eiseler T, Storz P. Döppler H, et al. J Biol Chem. 2013 Jan 4;288(1):455-65. doi: 10.1074/jbc.M112.397448. Epub 2012 Nov 12. J Biol Chem. 2013. PMID: 23148218 Free PMC article. - A functional comparison between the HER2(high)/HER3 and the HER2(low)/HER3 dimers on heregulin-β1-induced MMP-1 and MMP-9 expression in breast cancer cells.
Kim S, Han J, Shin I, Kil WH, Lee JE, Nam SJ. Kim S, et al. Exp Mol Med. 2012 Aug 31;44(8):473-82. doi: 10.3858/emm.2012.44.8.054. Exp Mol Med. 2012. PMID: 22627808 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical
Research Materials
Miscellaneous